Inicio・Lista de Acciones・Medpace Holdings Inc

Medpace Holdings Inc

Cerrado

SectorSanidad

530.86 0.86

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

513.1

Máximo

537.07

Métricas clave
By Trading Economics
Ingresos	-11M 124M
Ventas	-1.8M 707M
P/B Media del Sector	33.224 62.58
BPA	4.28
Margen de beneficios	17.53
Empleados	6,300
EBITDA	-9.5M 154M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	-10.43% downside

Dividendos
By Acuity
Próximas Ganancias	22 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-14M 15B
Apertura anterior	530
Cierre anterior	530.86

Noticias sobre sentimiento de mercado

By Acuity

50%

145 / 340 Clasificación en Healthcare

Medpace Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 jul 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Comparación entre iguales

Cambio de precio

Medpace Holdings Inc previsión

Precio Objetivo

By TipRanks

-10.43% descenso

Estimación a 12 Meses

Media 472.89 USD -10.43%

Máximo 586 USD

Mínimo 393 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medpace Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

9 ratings

Comprar

Mantener

Vender

De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Medpace Holdings Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

145 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.